Dr. Loice Ombajo made history when she got published in the New England Journal of medicine on Thursday, June 22, 2023. 

In an exclusive interview by the Directorate of Corporate Affairs, Dr. Ombajo revealed the content of her research article titled, ‘Second-line switch to Dolutegravir for treatment of HIV infection.’ She gave a brief history of what led to the research through clinical trials that took about 48 weeks. She underscored how  rare it is for an African black woman researcher to be featured in such a high end journal.